Statement: There is only 1 adverse event in the primary trial that occurred more than once.
Primary_evidence: Adverse Events 1:   Total: 14/58 (24.14%)   Constipation 1/58 (1.72%)   Vomiting 1/58 (1.72%)   Upper gastrointestinal haemorrhage 1/58 (1.72%)   Asthenia 1/58 (1.72%)   Chest pain 1/58 (1.72%)   Pain 1/58 (1.72%)   Sepsis 2/58 (3.45%)   Fall 1/58 (1.72%)   Spinal compression fracture 1/58 (1.72%)   Neutrophil count decreased 1/58 (1.72%)   Dehydration 1/58 (1.72%)   Hypovolaemia 1/58 (1.72%)